DTE vs SOLV
DTE (DTE) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
DTE does not have a complete income-statement cache yet.
Latest reported SOLV revenue for 2024-12-31 was $8.25B. Net income was $479.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
DTE currently screens at market cap $0. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the DTE and SOLV stock pages for the full models.
Not investment advice.